Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Raf

Items 11-20 of 27

Page
per page
  1. B-Raf inhibitor 1
    B1172 B-Raf inhibitor 1
    Summary: Potent and selective B-Raf inhibitor
      ≥47.9 mg/mL
  2. LY3009120
    A8716 LY3009120
    Target: Raf
    Summary: pan-RAF and RAF dimer inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.25 mg/mL
  3. ZM336372
    A8545 ZM336372
    Summary: C-Raf inhibitor, potent and selective
      insoluble in EtOH; insoluble in H2O; ≥19.45 mg/mL
  4. AZ 628
    A8371 AZ 628
    Summary: Raf kinases,potent and ATP-competitive
      ≥22.6 mg/mL
  5. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  6. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  7. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL
  8. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  9. MLN 2480
    A3627 MLN 2480
    Summary: Pan-Raf kinase inhibitor,investigational
      ≥50.6 mg/mL
  10. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL

Items 11-20 of 27

Page
per page